You are here

Towards Personalized Neuromodulation


Warning message

This Grand Rounds Webinar is restricted to registered participants or on-demand registrants. Click the following link to register: Register Here

Presenting: Towards Personalized Neuromodulation

Learning objectives:
1. Learners be able to describe patterns of clinical response to TMS
2.Learners will be able to identify individualized TMS targeting approaches based on patient-specific symptoms
3. Learners will be able to understand investigational approaches to individualized brain mapping for TMS targeting

Date of Release: March 15, 2019

Date of Expiration: March 14, 2021

Format: On-Demand

Cost: Members: $25 | Non-members $50

Bibliographic Sources: See slides for bibliographic sources for further study

Method of Physician Participation
Learners will listen to each audio self-directed module while following along with the visual slides. Upon completion, each learner will answer evaluation questions to receive their CE certificate.

Acknowledgement of Commercial Support

No financial or in-kind commercial support was received for this educational activity.


Disclosure of Conflict of Interest

The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-­‐6.2, 6.5)


All individuals in a position to control the content of CE are listed below.

First Name

Last Name

Commercial Interest



Neuronetics: Other



SigNeuro LLC: Stock Shareholder








Speakers: Shan Siddiqi, MD

Dr. Siddiqi is a neuropsychiatrist and the Sidney R. Baer Fellow in Clinical Neuroscience at Harvard Medical School and the Berenson-Allen Center for Noninvasive Brain Stimulation. Clinically, his interests include behavioral effects of focal brain lesions and therapeutic brain stimulation. His research is focused on developing better methods for individualizing neuromodulatory treatments based on functional MRI (fMRI) and clinical phenomenology. He has been involved in several trials involving individualized brain network mapping to target TMS for depression associated with traumatic brain injury. He is now working on developing computational models for using brain stimulation to explain human behavior. This includes mapping of human emotional circuits via novel approaches to data acquired from functional MRI, TMS, deep brain stimulation, and brain lesions. He uses this approach to develop individualized brain stimulation targets based on patient-specific symptoms and imaging findings.


Phone: 845-392-3238


Vertical Tabs

Vertical Tabs